Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Gorwood P., Neznanov N. G., ...More

SCHIZOPHRENIA RESEARCH, vol.169, pp.393-399, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 169
  • Publication Date: 2015
  • Doi Number: 10.1016/j.schres.2015.08.015
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Page Numbers: pp.393-399
  • Istanbul University Affiliated: Yes


Objective: Relapse and acute exacerbation are common in schizophrenia and may impact treatment response and outcome. Evidence is conflicting in respect to superiority of long-acting injectable antipsychotic therapies versus oral antipsychotics in relapse prevention. This randomized controlled study assessed the efficacy of paliperidone palmitate versus oral antipsychotics for relapse prevention.